Clinical Trial Update: Botox for the Treatment of Chronic Exertional Compartment Syndrome [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial evaluating Botox for chronic exertional compartment syndrome in the leg was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Compartment Syndrome of the Leg

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Compartment Syndrome of Leg | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2023-02-14